MERITAGE PORTFOLIO MANAGEMENT HALO Holdings History
MERITAGE PORTFOLIO MANAGEMENT's Halozyme Therapeutics Inc Holding Summary
As of 2025-03-31, MERITAGE PORTFOLIO MANAGEMENT held 101,651.00 shares of Halozyme Therapeutics Inc(HALO), totaling $6.49 Mil. This investment constitutes 0.43% of their stock portfolio, and MERITAGE PORTFOLIO MANAGEMENT now holds 0.08% of the outstanding Halozyme Therapeutics Inc(HALO) stock.
The initial trade took place in 2022Q3. And since then MERITAGE PORTFOLIO MANAGEMENT has made 2 purchases of HALO, at an average price of $48.81, for a total of 306,228.00 shares. In addition, there have been 2 sales at an average price of $47.05 for 204,577.00 shares. Based on historical transaction data and HALO's current price of $55.92, MERITAGE PORTFOLIO MANAGEMENT's estimated gain on his HALO holdings is $361,860.44, reflecting a 2.42% gain to date.
MERITAGE PORTFOLIO MANAGEMENT HALO ($55.92) Holding Chart
MERITAGE PORTFOLIO MANAGEMENT HALO ($55.92) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
